₹3,355.00
COMPOSITION
Cefuroxime Axetil 250mg Tab
PACKING
10x1x10 (Alu-Alu)
PECXIME 250 Tablets contain Cefuroxime Axetil 250mg, a widely trusted second-generation cephalosporin antibiotic used for the treatment of a broad range of bacterial infections. Known for its excellent safety profile and strong antibacterial activity, it effectively targets both gram-positive and gram-negative bacteria, making it a go-to prescription for doctors managing common community-acquired infections.
Cefuroxime Axetil is a prodrug of Cefuroxime, which becomes active after absorption in the gastrointestinal tract. It works by inhibiting bacterial cell wall synthesis, leading to the destruction of bacteria and quick recovery from infection. With its broad coverage and high efficacy, PECXIME 250 is recommended in respiratory, urinary, skin, ENT, and soft tissue infections.
PECXIME 250 is prescribed for the treatment of:
✅ Broad-spectrum activity – Effective against a wide range of bacteria
✅ Reliable antibiotic choice – Commonly prescribed for respiratory, urinary, and skin infections
✅ Proven efficacy – Trusted cephalosporin with high clinical success rate
✅ Oral formulation – Convenient for outpatient treatment
✅ Faster recovery – Provides quick symptom relief and bacterial clearance
✅ Safe for adults and children when taken under medical supervision
Cefuroxime Axetil is converted to Cefuroxime in the body after oral administration. It works by binding to bacterial enzymes (penicillin-binding proteins) and disrupting the synthesis of the bacterial cell wall. This weakens the bacterial structure, causing cell lysis and death.
Its broad antibacterial spectrum makes it effective against both gram-positive organisms like Streptococcus and Staphylococcus and gram-negative organisms like E. coli, H. influenzae, and Klebsiella. Our Products
“Cefuroxime Axetil remains a reliable oral cephalosporin antibiotic for both respiratory and urinary infections. PECXIME 250 provides effective antibacterial coverage with good patient compliance, especially for community-acquired infections where resistance is a growing concern.” –
Reviews
There are no reviews yet.